Corvus Pharmaceuticals Inc (CRVS.OQ)
CRVS.OQ on NASDAQ Stock Exchange Global Market
10.66USD
20 Apr 2018
10.66USD
20 Apr 2018
Change (% chg)
$0.01 (+0.09%)
$0.01 (+0.09%)
Prev Close
$10.65
$10.65
Open
$10.65
$10.65
Day's High
$11.06
$11.06
Day's Low
$10.55
$10.55
Volume
15,477
15,477
Avg. Vol
40,708
40,708
52-wk High
$17.54
$17.54
52-wk Low
$7.45
$7.45
Consensus Recommendations
Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
---|---|---|---|
Outperform | -0.79 | December | 21 Apr 2018 |
Analyst Recommendations and Revisions
1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
---|---|---|---|---|
(1) BUY | 3 | 3 | 3 | 3 |
(2) OUTPERFORM | 2 | 2 | 2 | 2 |
(3) HOLD | 1 | 1 | 1 | 1 |
(4) UNDERPERFORM | 0 | 0 | 0 | 0 |
(5) SELL | 0 | 0 | 0 | 0 |
No Opinion | 0 | 0 | 0 | 0 |
Mean Rating | 1.67 | 1.67 | 1.67 | 1.67 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
# of Estimates | Mean | High | Low | 1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
Quarter Ending Sep-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
Year Ending Dec-18 | 3 | 0.00 | 0.00 | 0.00 | 0.00 |
Year Ending Dec-19 | 4 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | 5 | -0.79 | -0.69 | -0.86 | -- |
Quarter Ending Sep-18 | 5 | -0.76 | -0.60 | -0.86 | -- |
Year Ending Dec-18 | 4 | -3.14 | -2.82 | -3.42 | -3.89 |
Year Ending Dec-19 | 6 | -3.29 | -2.19 | -4.30 | -3.95 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
---|---|---|---|---|
SALES (in millions) | ||||
Quarter Ending Dec-17 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Sep-17 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Jun-17 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Dec-16 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarter Ending Sep-16 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings (per share) | ||||
Quarter Ending Dec-17 | -0.77 | -0.58 | 0.19 | -24.56 |
Quarter Ending Sep-17 | -0.81 | -0.62 | 0.19 | -23.74 |
Quarter Ending Jun-17 | -0.74 | -0.73 | 0.01 | -1.08 |
Quarter Ending Mar-17 | -0.77 | -0.79 | 0.02 | -2.56 |
Quarter Ending Dec-16 | -0.57 | -0.55 | 0.02 | -2.79 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
---|---|---|---|---|---|
SALES (in millions) | |||||
Quarter Ending Jun-18 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
Quarter Ending Sep-18 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
Year Ending Dec-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Year Ending Dec-19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings (per share) | |||||
Quarter Ending Jun-18 | -0.79 | -0.79 | -0.79 | -0.86 | -- |
Quarter Ending Sep-18 | -0.76 | -0.76 | -0.76 | -0.81 | -- |
Year Ending Dec-18 | -3.14 | -3.14 | -3.14 | -3.29 | -3.89 |
Year Ending Dec-19 | -3.29 | -3.29 | -3.29 | -3.40 | -3.95 |
Estimates Revisions Summary
Last Week | Last 4 Weeks | |||
---|---|---|---|---|
Number Of Revisions: | Up | Down | Up | Down |
Revenue | ||||
Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-19 | 0 | 0 | 0 | 0 |
Earnings | ||||
Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-18 | 0 | 0 | 0 | 0 |
Year Ending Dec-19 | 0 | 0 | 0 | 0 |
- BRIEF-Adams Street Partners Reports 15.5 Pct Stake In Corvus Pharma
- BRIEF-BVF Partners Reports 6.7 Pct Passive Stake In Corvus Pharmaceuticals
- BRIEF-Corvus Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
- BRIEF-Corvus Pharma Announces Pricing Of Public Offering Of Common Stock
- BRIEF-Corvus Pharma Announces Proposed Public Offering Of Common Stock